DRDmitry Igorevich Rudenko

Dmitry Igorevich Rudenko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dmitry Igorevich Rudenko has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Determinants of the effectiveness of medical rehabilitation of children with congenital myopathies

    by V.M. Suslov, G.N. Ponomarenko, D.I. Rudenko, G.A. Suslova, A.D. Suslova, O.V. Bulina

    Congenital myopathies (CM) are a heterogeneous group of inherited primary muscular diseases characterized by muscle weakness, hypotonia, movement disorders, and decreased exercise tolerance. In the absence of etiotropic therapy for most forms of CM, medical rehabilitation remains of key importance; however, its personalization requires identifying the factors influencing the rehabilitation outcome. The aim of the study was to evaluate the effectiveness of medical rehabilitation, identify the determinants of effectiveness, and predict the rehabilitation outcome in children with congenital myopathies. Material and methods. The study included 32 patients with genetically confirmed forms of CM with a limbgirdle phenotype at the outpatient stage of the disease; the average age was 9.6±3.8 years. For 8 months, the patients underwent a comprehensive MR program, including exercise therapy, mechanokinesitherapy, balance training, breathing exercises, and hydrokinesitherapy. The assessment was conducted at baseline, after 4 and 8 months using the 6MWT, timed motor tests, section D1 of the MFM scale and lower limb muscle dynamometry. Statistical analysis included the Wilcoxon test, Spearman correlation analysis and multivariate regression analysis. Results. After the MR course, the 6MWT distance increased from 462.0±102.4 to 512.7±114.8 m (p<0.01), the MFM D1 indicator — from 84.2±10.4 to 91.1±8.4 % (p<0.01). Statistically significant improvement in the timed test results and lower limb muscle strength were noted. The determinants of MR effectiveness were the time to descend and ascend 4 steps, body weight, height and knee flexor muscle strength. The regression model was highly significant (p<0.001) and accurate (R²=87.9 %). Positive dynamics exceeding the minimum clinically significant difference in 6MWT were detected in 84.4 % of patients. Conclusion. Comprehensive personalized MR in children with congenital myopathies has a significant locomotor-corrective effect. The greatest effectiveness is achieved in patients with initially mild motor impairments, emphasizing the importance of early rehabilitation.

  • Determinants of the effectiveness of medical rehabilitation of patients with duchenne muscular dystrophy at ambulatory stages of the disease

    by Federal State Budgetary Educational Institution of Higher Education «St. Petersburg State Pediatric Medical University» of the Ministry of Health of the Russian Federation, V. M. Suslov, D. I. Rudenko, G. A. Ponomarenko, Federal State Budgetary Institution Federal Scientific and Educational Centre of Medial and Social Expertise and Rehabilitation named after. G. A. Albrecht of the Ministry of Labour and Social Protection of the Russian Federation, G. A. Suslova, O. V. Bulina, A.D. Suslova, Saint Petersburg Saint Petersburg State Budgetary Healthcare Institution «Children’s City Polyclinic No. 29», A.D. Rubin, et al.

    Objective: to study the mechanisms of therapeutic action, identify the determinants of effectiveness and prognosis of medical rehabilitation of patients with Duchenne muscular dystrophy (DMD) at the outpatient stages of the disease. Material and methods. The study included 86 patients with genetically confirmed DMD (mean age 7.5 ± 2.4 years). All patients performed a set of aerobic exercise therapy exercises, exercises on a stationary bicycle and courses of hydrokinesitherapy for 8 months. Dynamic assessment of clinical indicators using the MFM scale, goniometry of lower limb joints, dynamometry of lower limb muscle strength, anthropometric indicators, quantitative MRI of the pelvic girdle muscles, thighs and shins, questionnaires (PODCI, EQ-5D and SAN scales) were conducted. Results. The study revealed a high and significant correlation between quantitative MRI data and the severity of fibrofatty degeneration of the quadriceps femoris, hamstrings, gluteal muscles, and plantar flexors (r=0.789–0.658, p<0.01). A high and significant correlation was also found with lower limb dynamometry parameters (r=0.691–0.564, p<0.01), patient body weight (r=–0.692, p<0.01), and questionnaire results (r=–0.804–0.612, p<0.01). Factor analysis enabled us to identify 5 key parameters, with the severity of skeletal muscle fat replacement being the leading one. The main therapeutic effect is achieved by improving clinical parameters and enhancing patients’ quality of life while maintaining the severity of fibrofatty degeneration. The main determinants of the effectiveness of medical rehabilitation for patients with DMD were the severity of loss of gluteal, quadriceps, and plantar flexor strength; body weight, height, and BMI; the severity of fibrofatty degeneration of the gluteus maximus and vastus lateralis muscles, assessed using quantitative MRI; and the range of motion of the ankles. Conclusion. The best rehabilitation results according to the developed program were achieved in patients with DMD in the early outpatient stage, where the effectiveness rate was 85.5 %. In contrast, in patients in the late outpatient stage, positive dynamics were observed in only 12.5 % of cases.

  • Neuroimaging markers of safety of physical therapy exercises in children with muscular dystrophies

    by Vasily M. Suslov, Dmitry Igorevich Rudenko, Gennady N. Ponomarenko, Galina A. Suslova, Damir A. Malekov, Aleksandra D. Suslova

    BACKGROUND: Muscular dystrophies are a broad and heterogeneous group of hereditary neuromuscular disorders, most commonly manifesting with primary symmetric involvement of proximal skeletal muscles in the upper and lower limbs. Patients with these disorders are at increased risk of muscle fiber damage if exercises and their intensity are inappropriately selected during physical therapy. At present, no neuroimaging markers are available to assess the safety of physical exercise in patients with inherited myopathies. Quantitative MRI criteria for detecting clinically significant changes in skeletal muscles have also not been developed. AIM: This study aimed to evaluate the safety of physical therapy exercises in pediatric patients with muscular dystrophies using neuroimaging, clinical, and laboratory methods. METHODS: The study included 86 patients with genetically confirmed Duchenne muscular dystrophy (mean age 7.5 ± 2.4 years) and 42 patients with limb-girdle muscular dystrophies (mean age 11.8 ± 3.3 years). All patients underwent a 4-month rehabilitation program consisting of aerobic physical therapy exercises, stretching, and cycle ergometer training. Safety was assessed using clinical, laboratory, and neuroimaging measures. RESULTS: According to MRI findings, no statistically significant increase in T2 water signal intensity was observed after aerobic exercises without load in the major muscle groups of the pelvic and shoulder girdles, thighs, and calves in either group, indicating no progression of nonspecific inflammation or edema. All reported adverse events were mild and short-term, did not affect the rehabilitation, or require additional pharmacological or non-pharmacological treatment. Eight cases of skeletal muscle injury were observed, attributable to concentric or eccentric exercises. In the Duchenne muscular dystrophy group, the mean skeletal muscle signal intensity before exercise was 34.9 ± 1.0 ms and increased to 44.1 ± 3.7 ms during follow-up (p 0.01). In the limb-girdle muscular dystrophies group, signal intensity was 33.6 ± 2.3 ms and 44.3 ± 4.1 ms, respectively (p 0.01). CONCLUSION: Thus, the developed rehabilitation program, which includes aerobic exercises without load, does not result in skeletal muscle damage in patients with various forms of muscular dystrophy, as confirmed by neuroimaging, clinical, and laboratory assessments. In patients with Duchenne muscular dystrophy, skeletal muscle MR signal intensity from water increased on average by 20.4 ± 5.8%, whereas in patients with limb-girdle muscular dystrophies it increased by 23.8 ± 6.3%. This increase is clinically significant and indicates skeletal muscle injury accompanied by corresponding symptoms.

  • Clinical case, dynamics of the disease in a patient with Emery–Dreyfus muscular dystrophy caused by a mutation in the SYNE2 gene

    by Vasily M. Suslov, Dmitry O. Ivanov, Dmitry I. Rudenko, Larisa N. Liberman, Galina A. Suslova

    Emery–Dreyfus muscular dystrophy is a genetically heterogeneous disease with X-linked recessive, autosomal dominant and autosomal recessive forms, which can be caused by mutations in the EMD, LMNA, SYNE1 and SYNE2 genes. Emery–Dreyfus muscular dystrophy caused by a mutation in the SYNE2 gene is characterized by an autosomal dominant mode of inheritance with the onset of clinical symptoms in childhood. This form is characterized primarily by proximal muscle weakness of the upper and lower extremities and cardiac complications. The article describes a patient with Emery–Dreyfus muscular dystrophy caused by a mutation in the SYNE2 gene. The article presents clinical and instrumental examination methods, the dynamics of the course of the disease. During the observation period of 6 months, the patient showed a significant decrease in motor functions — a decrease in the distance of the 6-minute walking test, the ability to walk and move (D1) on the scale “motor function measure”, the results of speed tests. The patient also has a steadily progressive impairment of respiratory and bulbar functions, which requires regular dynamic monitoring, every day monitoring of oxygen saturation, and night and daytime non-invasive artificial ventilation is indicated. Taking into account the literature data and previously described clinical cases, the patient is characterized by a high risk of developing heart rhythm disturbances and dilated cardiomyopathy, which requires proper monitoring at least once every 6 months.


  • Open Access

    Efficacy and safety of Viltepso® in Duchenne muscular dystrophy: review of clinical studies

    by V. M. Suslov, D. I. Rudenko

    The author presents a literature review on the safety and efficacy of antisense oligonucleotides in the treatment of Duchenne muscular dystrophy using the exon skipping method using Viltepso® (viltolarsen), the only drug of this class registered in Russia, as an example. The analysis of international publications on clinical trials showed a high level of efficacy and safety of Viltepso®. This article, among other things, describes a 4-year clinical trial of viltolarsen. To date, this is the longest clinical trial of drugs of this group for the treatment of Duchenne muscular dystrophy. At the same time, it should not be forgotten that any pathogenetic therapy for Duchenne muscular dystrophy does not cure, but only slows down the progression of the disease, transferring it to a clinical form similar to Becker muscular dystrophy, provided that therapy is started early. In this regard, none of the currently available pathogenetic therapy can be considered as a monotherapy for the disease. Pathogenetic therapy will be most effective and will bring the desired results only with timely initiation of treatment and in combination with glucocorticosteroid therapy, symptomatic therapy and medical rehabilitation.

  • The influence of hydrokinesitherapy on motor and cardiorespiratory functions in hereditary myopathy of childhood

    by V.M. Suslov, L.N. Lieberman, G.N. Ponomarenko, D.I. Rudenko, G.A. Suslova

    Objective. To evaluate the impact of regular hydrokinesotherapy sessions and indicators of cardiorespiratory functions on the motor abilities of patients with hereditary myopathy of childhood. Material and methods. The study included 63 patients with genetically confirmed hereditary myopathy. Group 1 included 32 patients with Duchenne muscular dystrophy (DMD) who were in the early ambulatory stage. Group 2 included 15 patients at the late ambulatory stage. Group 3 included 16 patients with genetically confirmed forms of congenital myopathy. All patients performed a set of exercises, including dynamic aerobic exercises in the pool. The duration of the rehabilitation course was 4 months. At baseline and during follow-up after 2 and 4 months, we assessed: the distance of a 6-minute walk test (6-MWT) with fatigue assessment on a visual analogue scale (VAS) at the end of testing, time tests (running a distance of 10 m, climbing 4 steps) with determination of the functional class (FC) of test performance, spirometry indicators. Results. Over 4 months of regular training, there were a positive dynamics in the results of a 6-MWT, a decrease in fatigue according to VAS, an improvement in running time of 10 meters’ distance and the speed of climbing 4 steps, and an improvement in the FC of performing tasks (p≤0.01) in groups of patients with DMD at an early ambulatory stage and with congenital myopathies. An improvement in external respiratory function was found in all groups (p≤0.01). A significant correlations between body weight and BMI and a moderate correlation between the age of patients and indicators of motor abilities were revealed. There was a noticeable correlation between heart rate and the severity of fatigue when performing 6-MWT and running time of 10 meters’ distance. When analyzing EchoCG data, the ejection fraction and shortening fraction were characterized by a noticeable correlations with the speed of climbing of 4 steps and a moderate correlations with the results of 6-MWT, fatigue during its implementation, running time of 10 meters’ distance and its FC, as well as with the FC of climbing of 4 steps. Conclusion. Regular hydrokinesotherapy exercises can improve motor abilities, muscle endurance and speed in patients with DMD at the early ambulatory stage and in patients with congenital myopathies of childhood, as well as improve external respiratory function in patients with DMD and congenital myopathies in all ambulatory stages. In groups of patients with DMD, a significant relationship between indicators of speed, fatigue and endurance and the functional capabilities of the heart was revealed.


  • Physical medical rehabilitation of patients with dystrophinopathies: dynamics of the disease’s course considering clinical anthropometric indicators

    by V.M. Suslov, L.N. Liberman, D.I. Rudenko, D.O. Ivanov, G.A. Suslova, V.V. Kiryanova, A.D. Suslova

    Dystrophinopathies — a group of hereditary X-linked neuromuscular diseases characterized by worsening fibrofatty degeneration of skeletal muscles, muscular weakness, low exercise tolerance, as well as orthopedic, cardiovascular and respiratory complications. Study of the effectiveness of physical medical rehabilitation in patients with neuromuscular diseases, evaluation of the influence of external and internal factors on functional capabilities and effectiveness of the conducted rehabilitation are highly relevant. Objective. To evaluate the effectiveness of physical medical rehabilitation of patients with dystrophinopathies at the outpatient stages of the disease’s course and the influence of anthropometric characteristics and functional status of patients’ motor capabilities. Material and methods. The study included 47 patients with genetically confirmed Duchenne muscular dystrophy (DMD) (the 1st group — 32 patients at an early outpatient stage, mean age 7.0±0.2 years; the 2nd group — 15 patients at a late outpatient stage, mean age 9.0±0.2 years) and 17 patients with Becker muscular dystrophy (BMD) (the 3rd group, mean age 12.0±1.2 years). All patients performed aerobic exercises 3 times a week, the duration of rehabilitation course was 4 months. The distance of 6-minute walk test (6MWT) with fatigue assessment on the visual analogue scale, the speed of rising from the floor with assessment of the functional class on a 6-point scale, the functional capacities on the Motor Function Measure (MFM) scale, dimension D1 (standing and transfers) were evaluated at baseline and after 2 and 4 months. Results. Positive dynamics has been revealed in the form of elongating 6MWT distance, increasing speed of tests for time performance with increase of test’s functional class, improvement of motor functions on the MFM scale at the end of case follow-up in the 1st and 3rd groups (p<0.01). A high correlation of the patients’ motor capabilities with reduction of strength and speed indicators, moderate relationship with age and anthropometric indicators have been found (p<0.01). Conclusions. Performance of aerobic exercises without weight combined with exercises on an ergocycle allows to improve motor capabilities in patients with DMD at the early stages and in patients with BMD. Exercising at the late stages of DMD can slow down the disease’s progression. The dynamics of motor capabilities’ indicators in regular performance of dynamic aerobic exercises are more influenced by the initial functional status, less — by age and concomitant overweight and high body mass index.

  • Open Access

    Dynamics of the course of Duchenne muscular dystrophy in patients taking ataluren and concomitant drug and non-drug therapy

    by V. M. Suslov, L. N. Liberman, D. I. Rudenko, G. A. Suslova

    Background. Duchenne muscular dystrophy is a hereditary, X-linked, progressive, disabling disease. One of the possible pathogenetic methods for treating this disease is the drug ataluren, which acts at the stage of protein translation in the ribosome and makes it possible to read information from mRNA, despite the presence of a premature stop codon in it, and, as a result, synthesize the dystrophin protein.Aim. To evaluate the dynamics of the course of Duchenne muscular dystrophy in patients receiving appropriate drug and non-drug therapy and patients receiving pathogenetic therapy with ataluren.Materials and methods. We examined 38 patients with genetically confirmed Duchenne muscular dystrophy. Of these, 11 patients with a genetically confirmed nonsense mutation receiving pathogenetic therapy with ataluren and 27 patients in the comparison group with other mutations in the dystrophin gene. 6‑minute walk test and timed function tests was done at baseline and during follow-up. Ataluren side effects were assessed.Results. Statistically significant positive dynamics were revealed during follow-up at 12 month when assessing the distance of a 6‑minute walk test and tests for getting up from the floor and running 10 meters in groups taking ataluren and receiving standard drug therapy with the initial initiation of a course of regular physical exercise. The control group was characterized by negative dynamics in speed tests.Conclusion. Thus, when taking ataluren in the standard recommended dosage, patients with Duchenne muscular dystrophy with a nonsense mutation shows a decrease in the rate of disease progression and an improvement in speed and endurance. The initial prescription of regular non-weightbearing aerobic exercise on the early ambulatory stage is also characterized by an increase in motor skills.